Suppr超能文献

舒必利的药理学——一种多巴胺受体拮抗剂。

The pharmacology of sulpiride--a dopamine receptor antagonist.

作者信息

O'Connor S E, Brown R A

出版信息

Gen Pharmacol. 1982;13(3):185-93. doi: 10.1016/0306-3623(82)90088-x.

Abstract
  1. The clinical and experimental pharmacology of sulpiride, its effects on the CNS, gastrointestinal tract and cardiovascular system have been reviewed. 2. The majority of its actions are attributable to blockade of dopamine receptors. 3. Although sulpiride has a high affinity for dopamine receptors involved in emesis and prolactin secretion, it lacks part of the behavioural and biochemical profiles of the classical dopamine receptor antagonist neuroleptics. 4. In the cardiovascular system, sulpiride is a potent prejunctional dopamine receptor antagonist but has variable effectiveness in postjunctional dopamine receptor models. 5. These properties are discussed with reference to the mechanisms of action of sulpiride and the classification of dopamine receptors.
摘要
  1. 已对舒必利的临床和实验药理学、其对中枢神经系统、胃肠道和心血管系统的作用进行了综述。2. 其大部分作用归因于多巴胺受体的阻断。3. 尽管舒必利对参与呕吐和催乳素分泌的多巴胺受体具有高亲和力,但它缺乏经典多巴胺受体拮抗剂抗精神病药的部分行为和生化特征。4. 在心血管系统中,舒必利是一种强效的突触前多巴胺受体拮抗剂,但在突触后多巴胺受体模型中的有效性存在差异。5. 参照舒必利的作用机制和多巴胺受体的分类对这些特性进行了讨论。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验